Credit: VentureBeat made with OpenAI GPT-Image-1.5 The journey from a laboratory hypothesis to a pharmacy shelf is one of the ...
A study on visual language models explores how shared semantic frameworks improve image–text understanding across ...
GPT-Rosalind, a specialized AI model developed by OpenAI, focuses on life sciences and biomedical research. The launch ...
Anthropic is reportedly preparing Claude Opus 4.7 as it accelerates its AI release cycle, alongside new tools that could ...
GPT-Rosalind is OpenAI's first domain-specific model, built for drug discovery and life sciences—and it's not for everyone.
AGIBOT, a global leading robotics company specializing in embodied intelligence, today announced a new generation of embodied ...
AI factories are pushing data center power and cooling requirements beyond traditional limits, making integrated AI data ...
Cantargia AB (Publ) (Nasdaq Stockholm:CANTA) today reported that the rationale and study design of the phase 1b/2 clinical trial investigating nadunolimab in combination with immune-checkpoint ...
Large systems companies are pressing EDA vendors for performance improvements to keep pace with their AI workflows. The ...
Opinion
5don MSNOpinion
AI can design and run thousands of lab experiments without human hands. Humanity isn’t ready for the new risks this brings to biology
Artificial intelligence is rapidly learning to autonomously design and run biological experiments, but the systems intended to govern those capabilities are struggling to keep pace. AI company OpenAI ...
Hyundai has evolved from a budget-focused brand into a leader in cutting-edge design and electrification tech. In the process ...
Whilst chiplets garner much interest, many remain cautious about adopting multi-die solutions because the technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results